Synopsis: Eiko Lifesciences Limited, a Specialty Chemical Stock, reports 43.01% YoY revenue growth and a 360.71% YoY net profit surge in Q2 FY26 results.
This Specialty Chemical Stock, engaged in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals, jumped 7.36 percent after the company reported strong September quarterly results with a 360.71 percent YoY increase in net profit.
With a market capitalization of Rs. 82.33 crores, the share of Eiko Lifesciences Limited has reached an intraday high of Rs. 60.50 per equity share, rising nearly 7.36 percent from its previous day’s close price of Rs. 56.35. Since then, the stock has retreated and is currently trading at Rs. 60 per equity share.
Q2 FY26 Result Walkthrough:
Coming into the quarterly results of Eiko Lifesciences Limited, the company’s consolidated revenue from operations increased by 43.01 percent YOY, from Rs. 8.16 crore in Q2 FY25 to Rs. 11.67 crore in Q2 FY26, and grew by 8.96 percent QoQ from Rs. 10.71 crore in Q1 FY26.
Eiko Lifesciences Limited generated 87.84 percent of its revenue from the Speciality Chemicals & Pharma Intermediates segment and 12.16 percent from the Logistics Services Segment in Q2 FY26.
In Q2 FY26, Eiko Lifesciences Limited’s consolidated net profit increased by 360.71 percent YOY, reaching Rs. 1.29 crore compared to Rs. 0.28 crore during the same period last year. As compared to Q1 FY26, the net profit has increased by 16.22 percent, from Rs. 1.11 crore.
The basic earnings per share increased by 259.09 percent and stood at Rs. 0.22 as against Rs. 0.79 recorded in the same quarter in the previous year, FY2025.
Eiko Lifesciences Limited’s standalone revenue and net profit have grown at a CAGR of 28.3 percent and 29.96 percent, respectively, over the last four years.
In terms of return ratios, the company’s ROCE and ROE stand at 3.84 percent and 2.75 percent, respectively. Eiko Lifesciences Limited has an earnings per share (EPS) of Rs. 2.62, and its debt-to-equity ratio is 0.05x.
Company Overview:
Eiko Lifesciences Limited was incorporated on January 7, 1977, under the name Narendra Investments (Delhi) Limited, and changed its name to Eiko Lifesciences Limited in June 2021. The company has established itself as a manufacturer, supplier, and exporter of specialty and fine chemicals in India and internationally.
The company operates primarily in the manufacturing, processing, formulating, producing, buying, selling, and exporting of specialty chemicals and pharma intermediates. Its products include a diverse range of organic and inorganic specialty chemicals used across several industries, such as pharmaceuticals, agrochemicals, aroma chemicals, electronic chemicals, flavors and fragrances, and cosmetics.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
